Grantham, Mayo, Van Otterloo & Co (GMO)’s Axalta AXTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,532,501
Closed -$26.5M 751
2020
Q1
$26.5M Buy
1,532,501
+697,057
+83% +$17.8M 0.22% 71
2019
Q4
$25.4M Buy
+835,444
New +$24.6M 0.17% 100

Other funds holding AXTA

Grantham, Mayo, Van Otterloo & Co (GMO)'s AXTA Position: Q2 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Axalta (AXTA) in Q2 2020, closing a stake of 1,532,501 shares — an estimated $26.5M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AXTA in Q4 2019 and held it in 2 quarters. The position peaked at $26.5M in Q1 2020. 310 funds tracked by Wall St. Rank hold AXTA as of Q2 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Axalta position as of Q2 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,532,501 Axalta shares in Q2 2020, an estimated $26.5M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Axalta in Q4 2019 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Axalta position peaked at $26.5M in Q1 2020.
  • 310 funds tracked by Wall St. Rank held Axalta as of Q2 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2020, filed 13 Aug 2020.